119 related articles for article (PubMed ID: 8391608)
1. Plasma cGMP level as a marker of the hydration state in renal replacement therapy.
Lauster F; Heim JM; Drummer C; Fülle HJ; Gerzer R; Schiffl H
Kidney Int Suppl; 1993 Jun; 41():S57-9. PubMed ID: 8391608
[TBL] [Abstract][Full Text] [Related]
2. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD.
Plum J; Ziyaie M; Kemmer FW; Passlick-Deetjen J; Grabensee B
Adv Perit Dial; 1990; 6():211-9. PubMed ID: 1982811
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis.
Bald M; Bonzel KE; Rascher W
Clin Nephrol; 1994 Jul; 42(1):50-3. PubMed ID: 7923967
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
[TBL] [Abstract][Full Text] [Related]
6. Living on chronic hemodialysis between dryness and fluid overload.
Franz M; Pohanka E; Tribl B; Woloszczuk W; Hörl WH
Kidney Int Suppl; 1997 Jun; 59():S39-42. PubMed ID: 9185103
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of dry body-weight in hemodialysis patients by plasma cyclic 3'5'-guanosine monophosphate].
Xiao XC; Tao LJ
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):133-5. PubMed ID: 12536645
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.
Kohse KP; Feifel K; Mayer-Wehrstein R
Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377
[TBL] [Abstract][Full Text] [Related]
9. [Levels of immunoreactive atrial natriuretic peptide in the blood of children on hemodialysis therapy].
Jovanović O; Mirić-Nastić D; Popović-Rolović M; Antić-Peco A; Kostić M; Kruscić D
Srp Arh Celok Lek; 1992; 120(9-10):277-80. PubMed ID: 1306019
[TBL] [Abstract][Full Text] [Related]
10. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
Stangl K; Baumann G; Weil J; Gerzer R; Kerscher M; Blömer H
Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099
[TBL] [Abstract][Full Text] [Related]
11. [Values of atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in cardioversion].
Lechleitner P; Genser N; Hauptlorenz S; Putensen C; Mitterschiffthaler G; Artner-Dworzak E; Puschendorf B; Dienstl F
Z Kardiol; 1991 Sep; 80(9):574-9. PubMed ID: 1661054
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide (ANP) is removed by peritoneal dialysis in humans.
Fincher ME; Campbell HT; Sklar AH; Caruana RJ; Lightfoot BO; Cheek PL; Smith KL; Hess CP
Adv Perit Dial; 1989; 5():16-9. PubMed ID: 2577402
[TBL] [Abstract][Full Text] [Related]
13. [Clinical relevance of the determination of plasma atrial natriuretic peptide in children with chronic renal failure].
Rascher W; Bald M; Kröner F; Tulassay T; Müller-Wiefel DE
Z Kardiol; 1988; 77 Suppl 2():61-4. PubMed ID: 2970176
[TBL] [Abstract][Full Text] [Related]
14. The postdialytic plasma cyclic guanosine 3':5'-monophosphate level as a measure of fluid overload in chronic hemodialysis.
Lauster F; Fülle HJ; Gerzer R; Schiffl H
J Am Soc Nephrol; 1992 Mar; 2(9):1451-4. PubMed ID: 1320949
[TBL] [Abstract][Full Text] [Related]
15. Assessment of dry body-weight in haemodialysis patients by the biochemical marker cGMP.
Lauster F; Gerzer R; Weil J; Fülle HJ; Schiffl H
Nephrol Dial Transplant; 1990; 5(5):356-61. PubMed ID: 2165225
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of beta-adrenergic stimulation with dobutamine on the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with chronic heart failure.
Stangl K; Baumann G; Gerzer R; Weil J
Eur Heart J; 1991 Aug; 12(8):917-23. PubMed ID: 1655438
[TBL] [Abstract][Full Text] [Related]
17. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
Franz M; Woloszczuk W; Hörl WH
Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
[TBL] [Abstract][Full Text] [Related]
18. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis.
Nakatani T; Naganuma T; Masuda C; Uchida J; Sugimura T; Sugimura K
Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593
[TBL] [Abstract][Full Text] [Related]
19. Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure.
Eisenhauer T; Talartschik J; Scheler F
Klin Wochenschr; 1986; 64 Suppl 6():68-72. PubMed ID: 2948067
[TBL] [Abstract][Full Text] [Related]
20. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
